<p>先鋒集團在最近向證券交易委員會的披露中表示，在第四季度將其在藍鳥公司（NASDAQ:BLBD - 免費報告）股票的持股比例提高了 7.1%。該基金在季度內購買了 135,562 股後，持有該公司 2,041,085 股股票。截至其最近的 SEC 備案，先鋒集團持有藍鳥約 6.46% 的股份，價值為 95,931,000 美元。</p>
<ul>
<li>對於看漲投資者的三大高風險高回報投資</li>
</ul>
<p>其他對沖基金也對該公司的持倉進行了調整。凱通國際資產管理有限公司在第三季度將其在藍鳥的持股比例提高了 10,028.6%。凱通國際資產管理有限公司現在擁有 709 股該公司的股票，價值 41,000 美元，此前在上個季度又購買了 702 股。拉森金融集團在第三季度將其在藍鳥的持倉提高了 1,742.3%。拉森金融集團現在擁有 1,308 股該公司的股票，價值 75,000 美元，此前在此期間又購買了 1,237 股。NewEdge Advisors LLC 在第一季度將其在藍鳥的持倉提高了 30.9%。NewEdge Advisors LLC 現在擁有 2,885 股該公司的股票，價值 93,000 美元，此前在此期間又購買了 681 股。LSV 資產管理公司在第三季度購買了藍鳥的新頭寸，價值 98,000 美元。最後，瓊斯金融公司在第三季度將其在藍鳥的持倉提高了 184.0%。瓊斯金融公司現在擁有 1,903 股該公司的股票，價值 110,000 美元，此前在此期間又購買了 1,233 股。機構投資者和對沖基金持有該公司 93.59% 的股票。</p>
<h2>藍鳥股價上漲 2.4%</h2>
<p>NASDAQ:BLBD 週四開盤價為 71.00 美元。該公司的 50 日移動平均線為 59.99 美元，200 日移動平均線為 54.94 美元。公司的債務與股本比率為 0.28，流動比率為 1.83，速動比率為 1.27。藍鳥公司的 12 個月低點為 37.68 美元，12 個月高點為 81.51 美元。該公司的市值為 22.5 億美元，市盈率為 17.44，市盈率增長比率為 0.97，貝塔值為 1.38。</p>
<ul>
<li>CRISPR Therapeutics 是基因編輯領域的 NVIDIA 嗎？</li>
</ul>
<p>藍鳥（NASDAQ:BLBD - 獲取免費報告）最近於 5 月 6 日發佈了季度財報。該公司報告季度每股收益為 1.00 美元，超出市場共識預期的 0.88 美元，超出 0.12 美元。藍鳥的股本回報率為 53.68%，淨利潤率為 8.91%。該公司季度收入為 3.5264 億美元，而分析師預期為 3.3523 億美元。去年同期，該公司每股收益為 0.96 美元。與去年同期相比，該公司的收入下降了 1.7%。研究分析師預測藍鳥公司在當前財政年度將發佈 4.35 美元的每股收益。</p>
<h2>內部活動</h2>
<p>在其他藍鳥新聞中，首席財務官 Razvan Radulescu 於 2 月 19 日星期四出售了 3,925 股該公司的股票。股票以平均價格 60.98 美元出售，總價值為 239,346.50 美元。交易後，首席財務官直接持有 42,255 股該公司的股票，價值為 2,576,709.90 美元。這筆交易代表其持股比例減少了 8.50%。該交易在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。此外，首席運營官 Jeffrey Scott Sanfrey 於 3 月 4 日星期三出售了 5,192 股該公司的股票。股票以平均價格 58.54 美元出售，總價值為 303,939.68 美元。交易完成後，首席運營官直接持有 39,011 股該公司的股票，價值為 2,283,703.94 美元。這筆交易代表其持股比例減少了 11.75%。該銷售的 SEC 備案提供了更多信息。公司內部人士持有該公司 1.10% 的股票。</p>
<h2>分析師評級變動</h2>
<ul>
<li>基因療法：為什麼單次治療要花費數百萬？</li>
</ul>
<p>幾家券商最近對 BLBD 進行了評估。華爾街 Zen 在 2 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “買入”。Freedom Capital 在 5 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “持有”。Zacks Research 在週一的研究報告中將藍鳥的評級從 “持有” 下調至 “強烈賣出”。Needham &amp; Company LLC 在 5 月 7 日的研究報告中將藍鳥的目標價從 78.00 美元提高至 86.00 美元，並給予該股票 “買入” 評級。最後，巴克萊在 5 月 7 日的研究報告中將藍鳥的目標價從 55.00 美元提高至 75.00 美元，並給予該股票 “增持” 評級。六位股票研究分析師對該股票給予了買入評級，一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，藍鳥目前的平均評級為 “適度買入”，共識目標價為 75.80 美元。</p>
<p><strong>獲取我們最新的藍鳥股票分析</strong></p>
<h2>關於藍鳥</h2>
<p>（免費報告）</p>
<p>藍鳥公司（NASDAQ: BLBD）是總部位於喬治亞州福特谷的領先公交車和公共交通工具製造商。公司的核心業務包括設計、工程和生產校車和活動巴士，產品線包括常規（C 型）模型、公交風格（D 型）模型以及特殊需求和活動運輸的特殊配置。近年來，藍鳥擴展了其產品，推出了零排放電動校車，體現了其對先進推進技術和環境可持續性的承諾。</p>
<p>藍鳥成立於 1927 年，在學生交通運輸領域建立了安全和可靠的聲譽。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票而非 Blue Bird</li>
<li>D-Wave 的財報表現疲軟，但投資者可能忽視了這一點</li>
<li>隨着 AI 反饋循環加劇，Nebius 的上行空間擴大</li>
<li>內部交易：Okta 和 Abbott 看到買入，Micron 內部人士賣出</li>
<li>Plug Power 實現盈利的開關已開啓</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 $1,000 在 Blue Bird 嗎？</h2>
<p>在你考慮 Blue Bird 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Blue Bird 並不在名單上。</p>
<p>雖然 Blue Bird 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

BLBD

<p>先鋒集團（Vanguard Group Inc.）在第四季度將其在藍鳥公司（Blue Bird Corporation，NASDAQ:BLBD）的持股增加了 7.1%，目前持有 2,041,085 股，估值約為 9593 萬美元。其他對沖基金也顯著增加了他們的持倉。藍鳥公司的股票開盤價為 71.00 美元，市值為 22.5 億美元，市盈率為 17.44。該公司報告的季度每股收益為 1.00 美元，超出預期，儘管同比收入下降了 1.7%。近期有內部人士出售股票的情況，分析師評級各異，部分分析師下調了評級並調整了目標價格</p>

<p>Vanguard Group Inc. lifted its holdings in shares of Blue Bird Corporation (NASDAQ:BLBD - Free Report) by 7.1% during the 4th quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 2,041,085 shares of the company's stock after purchasing an additional 135,562 shares during the quarter. Vanguard Group Inc. owned about 6.46% of Blue Bird worth $95,931,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>先鋒集團在最近向證券交易委員會的披露中表示，在第四季度將其在藍鳥公司（NASDAQ:BLBD - 免費報告）股票的持股比例提高了 7.1%。該基金在季度內購買了 135,562 股後，持有該公司 2,041,085 股股票。截至其最近的 SEC 備案，先鋒集團持有藍鳥約 6.46% 的股份，價值為 95,931,000 美元。</p>
</div><ul>
<li>Top 3 High-Risk, High-Reward Plays for Bullish Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>對於看漲投資者的三大高風險高回報投資</li>
</ul>
</div><p>Other hedge funds have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Blue Bird by 10,028.6% during the third quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company's stock worth $41,000 after purchasing an additional 702 shares during the last quarter. Larson Financial Group LLC raised its position in shares of Blue Bird by 1,742.3% in the 3rd quarter. Larson Financial Group LLC now owns 1,308 shares of the company's stock worth $75,000 after buying an additional 1,237 shares during the period. NewEdge Advisors LLC raised its position in shares of Blue Bird by 30.9% in the 1st quarter. NewEdge Advisors LLC now owns 2,885 shares of the company's stock worth $93,000 after buying an additional 681 shares during the period. LSV Asset Management purchased a new position in shares of Blue Bird in the 3rd quarter worth $98,000. Finally, Jones Financial Companies Lllp raised its position in shares of Blue Bird by 184.0% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,903 shares of the company's stock worth $110,000 after buying an additional 1,233 shares during the period. Institutional investors and hedge funds own 93.59% of the company's stock.</p>
<div class="lb-trans"><p>其他對沖基金也對該公司的持倉進行了調整。凱通國際資產管理有限公司在第三季度將其在藍鳥的持股比例提高了 10,028.6%。凱通國際資產管理有限公司現在擁有 709 股該公司的股票，價值 41,000 美元，此前在上個季度又購買了 702 股。拉森金融集團在第三季度將其在藍鳥的持倉提高了 1,742.3%。拉森金融集團現在擁有 1,308 股該公司的股票，價值 75,000 美元，此前在此期間又購買了 1,237 股。NewEdge Advisors LLC 在第一季度將其在藍鳥的持倉提高了 30.9%。NewEdge Advisors LLC 現在擁有 2,885 股該公司的股票，價值 93,000 美元，此前在此期間又購買了 681 股。LSV 資產管理公司在第三季度購買了藍鳥的新頭寸，價值 98,000 美元。最後，瓊斯金融公司在第三季度將其在藍鳥的持倉提高了 184.0%。瓊斯金融公司現在擁有 1,903 股該公司的股票，價值 110,000 美元，此前在此期間又購買了 1,233 股。機構投資者和對沖基金持有該公司 93.59% 的股票。</p>
</div><h2>Blue Bird Trading Up 2.4%</h2>
<div class="lb-trans"><h2>藍鳥股價上漲 2.4%</h2>
</div><p>NASDAQ:BLBD opened at $71.00 on Thursday. The business's 50-day moving average is $59.99 and its two-hundred day moving average is $54.94. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.83 and a quick ratio of 1.27. Blue Bird Corporation has a 12 month low of $37.68 and a 12 month high of $81.51. The firm has a market capitalization of $2.25 billion, a PE ratio of 17.44, a price-to-earnings-growth ratio of 0.97 and a beta of 1.38.</p>
<div class="lb-trans"><p>NASDAQ:BLBD 週四開盤價為 71.00 美元。該公司的 50 日移動平均線為 59.99 美元，200 日移動平均線為 54.94 美元。公司的債務與股本比率為 0.28，流動比率為 1.83，速動比率為 1.27。藍鳥公司的 12 個月低點為 37.68 美元，12 個月高點為 81.51 美元。該公司的市值為 22.5 億美元，市盈率為 17.44，市盈率增長比率為 0.97，貝塔值為 1.38。</p>
</div><ul>
<li>Is CRISPR Therapeutics the NVIDIA of gene editing?</li>
</ul>
<div class="lb-trans"><ul>
<li>CRISPR Therapeutics 是基因編輯領域的 NVIDIA 嗎？</li>
</ul>
</div><p>Blue Bird (NASDAQ:BLBD - Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.88 by $0.12. Blue Bird had a return on equity of 53.68% and a net margin of 8.91%.The company had revenue of $352.64 million for the quarter, compared to analyst estimates of $335.23 million. During the same period last year, the company posted $0.96 earnings per share. The firm's revenue was down 1.7% compared to the same quarter last year. Research analysts predict that Blue Bird Corporation will post 4.35 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>藍鳥（NASDAQ:BLBD - 獲取免費報告）最近於 5 月 6 日發佈了季度財報。該公司報告季度每股收益為 1.00 美元，超出市場共識預期的 0.88 美元，超出 0.12 美元。藍鳥的股本回報率為 53.68%，淨利潤率為 8.91%。該公司季度收入為 3.5264 億美元，而分析師預期為 3.3523 億美元。去年同期，該公司每股收益為 0.96 美元。與去年同期相比，該公司的收入下降了 1.7%。研究分析師預測藍鳥公司在當前財政年度將發佈 4.35 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部活動</h2>
</div><p>In other Blue Bird news, CFO Razvan Radulescu sold 3,925 shares of the firm's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $60.98, for a total value of $239,346.50. Following the transaction, the chief financial officer directly owned 42,255 shares of the company's stock, valued at $2,576,709.90. This trade represents a 8.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Jeffrey Scott Sanfrey sold 5,192 shares of the firm's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $58.54, for a total value of $303,939.68. Following the completion of the transaction, the chief operating officer directly owned 39,011 shares in the company, valued at $2,283,703.94. This trade represents a 11.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.10% of the company's stock.</p>
<div class="lb-trans"><p>在其他藍鳥新聞中，首席財務官 Razvan Radulescu 於 2 月 19 日星期四出售了 3,925 股該公司的股票。股票以平均價格 60.98 美元出售，總價值為 239,346.50 美元。交易後，首席財務官直接持有 42,255 股該公司的股票，價值為 2,576,709.90 美元。這筆交易代表其持股比例減少了 8.50%。該交易在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。此外，首席運營官 Jeffrey Scott Sanfrey 於 3 月 4 日星期三出售了 5,192 股該公司的股票。股票以平均價格 58.54 美元出售，總價值為 303,939.68 美元。交易完成後，首席運營官直接持有 39,011 股該公司的股票，價值為 2,283,703.94 美元。這筆交易代表其持股比例減少了 11.75%。該銷售的 SEC 備案提供了更多信息。公司內部人士持有該公司 1.10% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><ul>
<li>Gene therapy: Why does it cost millions for a single treatment?</li>
</ul>
<div class="lb-trans"><ul>
<li>基因療法：為什麼單次治療要花費數百萬？</li>
</ul>
</div><p>Several brokerages recently weighed in on BLBD. Wall Street Zen lowered Blue Bird from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, February 7th. Freedom Capital lowered Blue Bird from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, May 7th. Zacks Research lowered Blue Bird from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report on Monday. Needham &amp; Company LLC increased their target price on Blue Bird from $78.00 to $86.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, May 7th. Finally, Barclays increased their target price on Blue Bird from $55.00 to $75.00 and gave the stock an &#34;overweight&#34; rating in a research report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Blue Bird presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $75.80.</p>
<div class="lb-trans"><p>幾家券商最近對 BLBD 進行了評估。華爾街 Zen 在 2 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “買入”。Freedom Capital 在 5 月 7 日的研究報告中將藍鳥的評級從 “強力買入” 下調至 “持有”。Zacks Research 在週一的研究報告中將藍鳥的評級從 “持有” 下調至 “強烈賣出”。Needham &amp; Company LLC 在 5 月 7 日的研究報告中將藍鳥的目標價從 78.00 美元提高至 86.00 美元，並給予該股票 “買入” 評級。最後，巴克萊在 5 月 7 日的研究報告中將藍鳥的目標價從 55.00 美元提高至 75.00 美元，並給予該股票 “增持” 評級。六位股票研究分析師對該股票給予了買入評級，一位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，藍鳥目前的平均評級為 “適度買入”，共識目標價為 75.80 美元。</p>
</div><p><strong>Get Our Latest Stock Analysis on Blue Bird</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的藍鳥股票分析</strong></p>
</div><h2>About Blue Bird</h2>
<div class="lb-trans"><h2>關於藍鳥</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Blue Bird Corporation NASDAQ: BLBD is a leading manufacturer of buses and mass transportation vehicles headquartered in Fort Valley, Georgia. The company's core business encompasses the design, engineering, and production of school buses and activity buses, with a product lineup that includes conventional (Type C) models, transit-style (Type D) models and specialty configurations for special-needs and activity transport. In recent years, Blue Bird has expanded its offerings to include zero-emission electric school buses, reflecting its commitment to advanced propulsion technologies and environmental sustainability.</p>
<div class="lb-trans"><p>藍鳥公司（NASDAQ: BLBD）是總部位於喬治亞州福特谷的領先公交車和公共交通工具製造商。公司的核心業務包括設計、工程和生產校車和活動巴士，產品線包括常規（C 型）模型、公交風格（D 型）模型以及特殊需求和活動運輸的特殊配置。近年來，藍鳥擴展了其產品，推出了零排放電動校車，體現了其對先進推進技術和環境可持續性的承諾。</p>
</div><p>Established in 1927, Blue Bird has built a legacy of safety and reliability in student transportation.</p>
<div class="lb-trans"><p>藍鳥成立於 1927 年，在學生交通運輸領域建立了安全和可靠的聲譽。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Blue Bird</li>
<li>D-Wave Earnings Looked Weak, But Investors May Be Missing This</li>
<li>Nebius Upside Expands as AI Feedback Loop Intensifies</li>
<li>Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell</li>
<li>Plug Power Flips The Switch On Profitability</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票而非 Blue Bird</li>
<li>D-Wave 的財報表現疲軟，但投資者可能忽視了這一點</li>
<li>隨着 AI 反饋循環加劇，Nebius 的上行空間擴大</li>
<li>內部交易：Okta 和 Abbott 看到買入，Micron 內部人士賣出</li>
<li>Plug Power 實現盈利的開關已開啓</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=BLBD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Blue Bird Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Blue Bird 嗎？</h2>
</div><p>Before you consider Blue Bird, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Blue Bird 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blue Bird wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Blue Bird 並不在名單上。</p>
</div><p>While Blue Bird currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Blue Bird 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Blue Bird Corporation $BLBD Shares Acquired by Vanguard Group Inc.

Market Beat

Vanguard Group Inc. 收購了 Blue Bird Corporation $BLBD 的股份